These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29596771)

  • 21. The Implementation of Marijuana Legalization in New York.
    Mitra S; Virani S
    Psychiatr Serv; 2019 Jul; 70(7):625-628. PubMed ID: 31056005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
    Sznitman SR; Zolotov Y
    Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students.
    Vujcic I; Pavlovic A; Dubljanin E; Maksimovic J; Nikolic A; Sipetic-Grujicic S
    Subst Use Misuse; 2017 Jul; 52(9):1225-1231. PubMed ID: 28605305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada.
    Bear D
    Int J Drug Policy; 2017 Apr; 42():97-101. PubMed ID: 28377052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004-2016.
    Orenstein DG; Glantz SA
    J Health Polit Policy Law; 2020 Feb; 45(1):73-109. PubMed ID: 31675092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.
    Fischer B; Russell C; Rehm J; Leece P
    J Public Health (Oxf); 2019 Jun; 41(2):412-421. PubMed ID: 29860521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the use of digital technologies to reduce the public health impacts of cannabis legalization in Canada.
    Bedrouni W
    Can J Public Health; 2018 Dec; 109(5-6):748-751. PubMed ID: 30097890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of marijuana for medical purposes.
    Pinkas J; Jabłoński P; Kidawa M; Wierzba W
    Ann Agric Environ Med; 2016 Sep; 23(3):525-8. PubMed ID: 27660881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Cannabis Decriminalization and Legalization on Road Safety Outcomes: A Systematic Review.
    Windle SB; Socha P; Nazif-Munoz JI; Harper S; Nandi A
    Am J Prev Med; 2022 Dec; 63(6):1037-1052. PubMed ID: 36167602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy.
    Lo SY; Winston-McPherson GN; Starosta AJ; Sullivan MD; Baird GS; Hoofnagle AN; Greene DN
    Am J Med; 2019 Mar; 132(3):347-353. PubMed ID: 30419224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The supply-side effects of cannabis legalization.
    Han J; Ng'ombe JN
    J Cannabis Res; 2022 Jul; 4(1):40. PubMed ID: 35864509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between legalization of cannabis use and traffic deaths in Uruguay.
    Nazif-Munoz JI; Oulhote Y; Ouimet MC
    Addiction; 2020 Sep; 115(9):1697-1706. PubMed ID: 32003494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Challenges of Projecting the Public Health Impacts of Marijuana Legalization in Canada Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts".
    Lake S; Kerr T
    Int J Health Policy Manag; 2017 May; 6(5):285-287. PubMed ID: 28812816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U.S. Policy Responses to Calls for the Medical Use of Cannabis.
    Hall W
    Yale J Biol Med; 2015 Sep; 88(3):257-64. PubMed ID: 26339208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug use in Canadian patients with trauma after cannabis legalization.
    Ball IM; Priestap F; Parry N; Pace J; Vogt KN
    Can J Surg; 2021 Jul; 64(4):E403-E406. PubMed ID: 34296708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding and learning from the diversification of cannabis supply laws.
    Kilmer B; Pacula RL
    Addiction; 2017 Jul; 112(7):1128-1135. PubMed ID: 27891693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Big data on a big new market: Insights from Washington State's legal cannabis market.
    Caulkins JP; Bao Y; Davenport S; Fahli I; Guo Y; Kinnard K; Najewicz M; Renaud L; Kilmer B
    Int J Drug Policy; 2018 Jul; 57():86-94. PubMed ID: 29709847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legalization of cannabis in Washington State: how is it going?
    Roffman R
    Addiction; 2016 Jul; 111(7):1139-40. PubMed ID: 26781325
    [No Abstract]   [Full Text] [Related]  

  • 40. Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia.
    Chiu V; Chan G; Hall W; Hides L; Lim C; Leung J
    Front Psychiatry; 2021; 12():551661. PubMed ID: 33716801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.